SCHEDULE: Goldman Sachs Reports Minimal Stake in Amedisys
Beneficial Ownership Report
Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC report a 0.0% beneficial ownership stake in Amedisys, Inc. common stock.
Summary
- The Goldman Sachs Group, Inc. and its subsidiary, Goldman Sachs & Co. LLC, filed an Amendment No. 1 to Schedule 13G regarding their beneficial ownership in AMEDISYS, INC.
- As of September 30, 2025, the aggregate amount beneficially owned by each reporting person is 190 shares of Common Stock.
- This represents 0.0% of the class of securities.
- Both entities report shared voting power over 170 shares and shared dispositive power over 190 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Amedisys, Inc.
Sentiment
Score: 5
Explanation: Neutral, as it's a routine disclosure of a very small, passive ownership stake with no material implications.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of a passive, minimal ownership stake by a major financial institution in a healthcare services company. It does not indicate any significant strategic move or broader industry trend.
Stakeholder Impact
- Minimal to no impact on shareholders, employees, customers, suppliers, or creditors of Amedisys, Inc. due to the de minimis ownership stake reported.
Key Dates
| Date | Description |
|---|---|
| 2024-07-29 | Previous Power of Attorney granted by The Goldman Sachs Group, Inc. superseded. |
| 2024-10-01 | Previous Power of Attorney granted by Goldman Sachs & Co. LLC superseded. |
| 2025-07-16 | Effective date of new Power of Attorney for The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC, valid until July 16, 2026. |
| 2025-09-30 | Date of event which requires filing of this statement (reporting period end for ownership calculation). |
| 2025-10-08 | Filing date of Schedule 13G Amendment No. 1 and Joint Filing Agreement. |
Keywords
Amedisys, Goldman Sachs, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Ownership, Healthcare Services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.